A successful antipsychotic combination trial. Quo Vadis?
- 6 September 2004
- journal article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 110 (4), 241-242
- https://doi.org/10.1111/j.1600-0447.2004.00370.x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapineActa Psychiatrica Scandinavica, 2004
- A Critical Review of Atypical Antipsychotic Utilization: Comparing Monotherapy with Polypharmacy and AugmentationCurrent Medicinal Chemistry, 2004
- Polypharmacy in schizophrenia: a fuzzy concept.The Journal of Clinical Psychiatry, 2003
- Reply to Polypharmacy in SchizophreniaThe Journal of Clinical Psychiatry, 2003
- Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinationsActa Psychiatrica Scandinavica, 2002
- Antipsychotic polypharmacy: evidence based or eminence based?Acta Psychiatrica Scandinavica, 2002
- Antipsychotic Polypharmacy, Part 1: Therapeutic Option or Dirty Little Secret?The Journal of Clinical Psychiatry, 1999
- Focus on Polypharmacy in schizophrenia: does anyone truly benefit?International Journal of Neuropsychopharmacology, 1999
- Focus on Antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?International Journal of Neuropsychopharmacology, 1999
- Sulpiride augmentation in people with schizophrenia partially responsive to clozapineThe British Journal of Psychiatry, 1997